BackgroundCheck.run
Search For

Thomas D Loughran, 39Harrisburg, PA

Known as:
Thomas Desmond Loughran
Related to:
Jose Antonio Santana 67

Thomas Loughran Phones & Addresses

Harrisburg, PA   

803 E Canal St, Lebanon, PA 17046   

104 Aspen St, Middletown, PA 17057   

Scranton, PA   

Mount Joy, PA   

Sheppard AFB, TX   

Camp Lejeune, NC   

Work

Company: Air national gaurd May 2010 Position: Heavy mobile equipment mechanic

Education

School / High School: York Technical Institute- York, PA 2010 Specialities: Certificate in Electrical

Ranks

Certificate: American Board of Internal Medicine Certification in Internal Medicine
Get Report
Control this profile

Mentions for Thomas D Loughran

Career records & work history

Medicine Doctors

Thomas P. Loughran

Specialties:
Orthopaedic Surgery
Work:
VCU Sports Medicine Center
1300 W Broad St STE 113, Richmond, VA 23284
804-8280713 (phone) 804-8280354 (fax)
Education:
Medical School
Virginia Commonwealth University SOM
Graduated: 1977
Procedures:
Arthrocentesis, Joint Arthroscopy, Knee Arthroscopy, Knee Replacement, Shoulder Arthroscopy, Shoulder Surgery
Conditions:
Fractures, Dislocations, Derangement, and Sprains, Internal Derangement of Knee, Internal Derangement of Knee Cartilage, Internal Derangement of Knee Ligaments, Intervertebral Disc Degeneration, Lateral Epicondylitis, Osteoarthritis, Plantar Fascitis, Rotator Cuff Syndrome and Allied Disorders, Spinal Stenosis
Languages:
English
Description:
Dr. Loughran graduated from the Virginia Commonwealth University SOM in 1977. He works in Richmond, VA and specializes in Orthopaedic Surgery. Dr. Loughran is affiliated with Virginia Commonwealth University Medical Center.

Thomas P. Loughran

Specialties:
Hematology/Oncology
Work:
Emily Couric Clinical Cancer Center
1240 Lee St, Charlottesville, VA 22908
434-9249333 (phone) 434-9821744 (fax)
Education:
Medical School
Hahnemann University School of Medicine
Graduated: 1979
Conditions:
Leukemia, Non-Hodgkin's Lymphoma, Anemia, Hemolytic Anemia, Rheumatoid Arthritis
Languages:
English
Description:
Dr. Loughran graduated from the Hahnemann University School of Medicine in 1979. He works in Charlottesville, VA and specializes in Hematology/Oncology. Dr. Loughran is affiliated with University Of Virginia Medical Center.
Thomas Loughran Photo 1

Thomas Patrick Loughran, Hershey PA

Specialties:
Internal Medicine
Medical Oncology
Hematology & Oncology
Work:
Pennsylvania State University
500 University Dr, Hershey, PA 17033H Lee Moffitt Cancer Ctr
12902 Usf Magnolia Dr, Tampa, FL 33612
Education:
Drexel University(1979) Medical Oncology
Thomas Loughran Photo 2

Thomas P Loughran, Hershey PA

Specialties:
Oncologist
Address:
500 University Dr, Hershey, PA 17033
1240 Lee St, Charlottesville, VA 22908
Education:
Hahnemann University - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Thomas Loughran resumes & CV records

Resumes

Thomas Loughran Photo 41

Thomas Loughran

Thomas Loughran Photo 42

Thomas Loughran

Thomas Loughran Photo 43

Thomas Loughran

Thomas Loughran Photo 44

Thomas Loughran

Thomas Loughran Photo 45

Thomas Loughran

Thomas Loughran Photo 46

Director At Penn State Hershey Cancer Institute

Location:
Harrisburg, Pennsylvania Area
Industry:
Research
Thomas Loughran Photo 47

Thomas Loughran

Location:
United States
Thomas Loughran Photo 48

Thomas Loughran - Lebanon, PA

Work:
Air National Gaurd May 2010 to 2000
Heavy Mobile Equipment Mechanic
Education:
York Technical Institute - York, PA 2010 to 2010
Certificate in Electrical

Publications & IP owners

Us Patents

Sphingosine 1-Phosphate Receptor Gene, Sppr

US Patent:
7964358, Jun 21, 2011
Filed:
Sep 10, 2010
Appl. No.:
12/879918
Inventors:
Thomas P. Loughran - Hummelstown PA, US
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68
G01N 33/53
US Classification:
435 6, 435 71
Abstract:
A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.

Differentially Expressed Genes In Large Granular Lymphocyte Leukemia

US Patent:
2004024, Dec 9, 2004
Filed:
Jan 28, 2004
Appl. No.:
10/766157
Inventors:
Thomas Loughran - Hummelstown PA, US
Ravi Kothapalli - Wesley Chapel FL, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The subject invention concerns gene sequences and the use thereof as markers for large granular lymphocyte (LGL) leukemia. The gene sequences of the invention are differentially expressed in LGL. Another aspect of the invention pertains to therapeutic compositions directed to gene expression and gene products of differentially expressed genes in LGL. The invention also concerns methods for screening and identifying compositions that may be of therapeutic benefit to patients having LGL leukemia and/or autoimmune disorders. In addition, because a large fraction of patients with T-LGL leukemia also have rheumatoid arthritis, these differentially expressed genes also represent novel targets for the diagnosis, prevention or treatment of rheumatoid arthritis and other autoimmune diseases.

Differentially Expressed Genes In Large Granular Lymphocyte Leukemia

US Patent:
2007002, Jan 25, 2007
Filed:
Jun 28, 2006
Appl. No.:
11/476407
Inventors:
Thomas Loughran - Hummelstown PA, US
Ravi Kothapalli - Wesley Chapel FL, US
International Classification:
A61K 48/00
C12Q 1/68
G01N 33/574
US Classification:
435006000, 435007230, 514044000
Abstract:
The subject invention concerns gene sequences and the use thereof as markers for large granular lymphocyte (LGL) leukemia. The gene sequences of the invention are differentially expressed in LGL. Another aspect of the invention pertains to therapeutic compositions directed to gene expression and gene products of differentially expressed genes in LGL. The invention also concerns methods for screening and identifying compositions that may be of therapeutic benefit to patients having LGL leukemia and/or autoimmune disorders. In addition, because a large fraction of patients with T-LGL leukemia also have rheumatoid arthritis, these differentially expressed genes also represent novel targets for the diagnosis, prevention or treatment of rheumatoid arthritis and other autoimmune diseases.

Possible Relatives

David A Loughran  Deborah F Loughran  Daniel D Loughran  Dennis J Loughran  Darcy L Loughran  Diane L Loughran  Donald M Loughran  Thomas D Johnson  Thomas Stamps  Thomas W Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.